Nanoparticle Contrast Agents for HCC Detection via X-ray Scatter
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current imaging techniques, such as ultrasound and CT/MRI scans, are inadequate for early detection of hepatocellular carcinoma (HCC) due to lack of definitive and reproducible methods, leading to misdiagnosis and poor prognosis.
Innovation Solution
A method involving nanoparticle compositions with a polymer layer and a binding agent, specifically designed to target cancer cells, using X-ray scatter imaging and spatial frequency heterodyne imaging to visualize and diagnose HCC, allowing for early detection and differentiation from normal tissues.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional imaging techniques (ultrasound, CT, MRI) are used, then the imaging process is simple and widely available, but the detection precision and ability to visualize small tumors is insufficient
Solution Approach 1:
The patent introduces nanoparticles as intermediary agents that accumulate in tumor tissues and serve as contrast enhancers for X-ray imaging. These nanoparticles mediate between the imaging system and the target tissue, providing the necessary contrast to visualize small tumors that would otherwise be indistinguishable from surrounding healthy tissue using conventional imaging methods.
Solution Approach 2:
The patent changes the physical parameters of the imaging system by introducing nanoparticles with specific X-ray scattering properties. The nanoparticles alter the X-ray interaction parameters (scattering cross-section, attenuation coefficients) in the tumor region, enabling detection of small tumors through enhanced contrast in the X-ray scatter images.
2Measurement precision
If nanoparticle compositions with polymer layers and binding agents are used, then the diagnostic accuracy and tumor visibility are enhanced, but the manufacturing complexity and cost increase
Solution Approach 1:
The nanoparticle composition is segmented into distinct functional components: a core nanoparticle for X-ray scattering, a polymer layer for stability and biocompatibility, and binding agents for tumor targeting. This segmentation allows each component to be optimized and manufactured separately using established techniques, then assembled into the final composite structure, making the complex system manufacturable.
Solution Approach 2:
The patent employs composite material structures combining nanoparticles with polymer coatings and binding agents. This composite approach leverages the advantageous properties of each material type - the X-ray scattering capability of nanoparticles, the biocompatibility and stability of polymers, and the specific binding affinity of targeting agents - creating a manufacturable composite that achieves high diagnostic accuracy.
3Measurement precision
If spatial frequency heterodyne imaging is used, then the ability to detect small tumors is improved, but the complexity of the imaging system and image processing increases
Solution Approach 1:
The patent transitions from conventional real-space imaging to spatial frequency domain imaging through heterodyne detection. By transforming the image processing into the frequency domain, the system can selectively enhance specific spatial frequency components associated with small tumor structures while filtering out background noise, improving detection capability despite increased system complexity.
Solution Approach 2:
The patent replaces direct real-space optical/mechanical imaging with a field-based heterodyne detection system that uses X-ray scattering and spatial frequency analysis. This substitution of the imaging mechanism enables detection of smaller features by exploiting wave interference and frequency domain processing, accepting increased system and computational complexity as a trade-off for improved detection precision.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enhances the visibility and detection of HCC tumors, improving diagnostic accuracy and prognosis by enabling the visualization of small tumors undetectable with conventional methods.
Implementation Method 1
detecting by X-ray scatter imaging the nanoparticle in the cells or the tissue
Data Source
AI summary
Methods, compositions, systems, devices and kits are provided herein for preparing and using a nanoparticle composition and spatial frequency heterodyne imaging for visualizing cells or tissues. In various embodiments, the nanoparticle composition includes at least one of: a nanoparticle, a polymer layer, and a binding agent, such that the polymer layer coats the nanoparticle and is for example a polyethylene glycol, a polyelectrolyte, an anionic polymer, or a cationic polymer, and such that the binding agent that specifically binds the cells or the tissue. Methods, compositions, systems, devices and kits are provided for identifying potential therapeutic agents in a model using the nanoparticle composition and spatial frequency heterodyne imaging.